Glaukos Corp.
- Address
- 1 Glaukos Way
Sponsor Overview
Specializations
Corneal Surface Disorders
Glaukos Corp. focuses on clinical research in persistent corneal epithelial defects, with attention to therapies intended to support corneal re-epithelialization and restore the integrity of the ocular surface.
- Persistent corneal epithelial defects
- Corneal epithelial healing
- Ocular surface repair
Its research activity is centered on ophthalmic treatment development for conditions where the cornea fails to heal normally, reflecting a narrow therapeutic emphasis within eye disease.
Ophthalmic Therapeutics
The sponsor’s clinical portfolio includes investigation of ophthalmic gel therapy for localized treatment of the corneal epithelium, highlighting interest in topical approaches for anterior segment disease.
- Topical ophthalmic therapy
- Anterior segment disease
- Corneal protection
This area reflects a therapeutic focus on eye-surface medication designed for direct application to damaged corneal tissue.
Corneal Imaging and Assessment
Clinical evaluation in the sponsor’s research includes fluorescein staining of the cornea and digital image review, indicating an interest in objective assessment of corneal healing and epithelial integrity.
- Fluorescein corneal staining
- Digital ocular imaging
- Central reading center
These assessment methods support precise monitoring of corneal wound closure and surface recovery in ophthalmology studies.
Ocular Tissue Repair
Glaukos Corp. is involved in research addressing tissue repair in the eye, with particular relevance to conditions requiring sustained restoration of the corneal surface over time.
- Ocular tissue regeneration
- Corneal wound healing
- Surface epithelial restoration
The therapeutic interest lies in interventions for patients with chronic corneal epithelial injury and incomplete healing of the ocular surface.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Lufepirsen Ophthalmic Gel for Safety and Efficacy in Persistent Corneal Epithelial Defects: A Randomized, Double-Masked, Vehicle-Controlled Phase 2 Study |  France Germany Italy Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 20 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases1 trial138 other sponsors
Partnered Research Centres
20 centres- Address
- Via Consolare Valeria N 1, 98124 Messina
- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Largo Giovanni Alessandro Brambilla 3, 50134 Florence
- Address
- Via Antonio Di Rudini' 8, 20142 Milan
- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
- Address
- 2 Avenue Martin Luther King, 87000 Limoges
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Glaukos Corp..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.